| EX1553 MYELOPROLIFERATIVE NEOPLASIA WITH EOSINOPHILIA |
| Specimen: |
3 mL (2 mL min.) whole blood from 1 Lavender Top (EDTA) tube AND 2 mL (1.5 mL min.) Bone marrow in 1 Lavender Top (EDTA) tube AND 3 mL (2 mL min.) Bone marrow in 1 Green Top (Sodium Heparin) tube. Ship at 18-22°C. DO NOT FREEZE. |
| Stability: |
| Room |
Refrigerated |
Frozen |
| 48 hrs |
NA |
NA |
|
| Method: |
Electrical impedance, Microscopy, FISH |
| Comment: |
Samples received on holidays will be reported in the next schedule / next working day. |
| Report: |
Contact us to know the TAT. |
| Usage: |
Myeloproliferative neoplasia (MPN) with Eosinophilia has been categorized as a separate disease entity with the rearrangement of the genes – PDGFRA, PDGRB & FGFR1 by the recent (2016) revision to the WHO classification of Myeloid neoplasms & Acute leukemia. Identification of these dysregulated fusion Tyrosine kinase (TK) genes is crucial for the therapeutic strategy and prognostication of these otherwise BCR-ABL1 negative Myeloproliferative neoplasias. This panel is precisely designed to identify these Myeloproliferative neoplasias of clinical significance. |
| Doctor Specialty: |
Oncologist, Hematologist |
| Disease: |
Myeloproliferative disease |
| Components: |
|
| Courier Charges: |
Included with MRP. |
| Home Collection: |
Available (*T&C Apply) |
| Department: |
CYTOGENETICS |
| Pre Test Information: |
A duly filled Chromosome & FISH Analysis Requisition form is mandatory. |
Reviews
There are no reviews yet.